TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/20/26 17:39 | 1/15/26 | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -54 | 2.07 | 0 | -26 | -6 | 390 | D | ||||||||||||||
6/20/25 16:08 | 6/18/25 | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -3 | 1.79 | 0 | -2 | -1 | 320 | D | ||||||||||||||
1/17/25 17:35 | 1/15/25 | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -38 | 2.20 | 0 | -17 | -5 | 320 | D | ||||||||||||||
6/20/24 17:03 | 6/18/24 | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -10 | 5.60 | 0 | -2 | -1 | 241 | D | ||||||||||||||
6/13/24 18:13 | 6/13/24 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | FL | D | S.d | -25 | 28.38 | 0 | -1 | -6 | 13 | D | |||||||||||||||
1/18/24 16:40 | 1/16/24 | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -85 | 8.74 | 0 | -10 | -2 | 391 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |